To those unfamiliar with the long, often bitter, struggle over equally compelling needs to provide, on the one hand, innovators with an adequate opportunity to recoup risk capital and to avoid, on the other, erecting unwarranted barriers to competition, a dispute over the proper scope of review for Patent and Trademark Office (PTO) patent appeals will seem both trivial and arcane. This case involves more than semantics -- its resolution turns on the allocation of power among three, and arguably four, branches of government. This Court, itself, has a stake
My main objective is directed at institutional questions, to help the PTO and Congress as each consi...
Increasingly, accused infringers challenge a patent’s validity in two different forums: in litigatio...
Last month, the Supreme Court heard oral arguments for a case called Arthrex, Inc. v. United States ...
Congress enacted the Administrative Procedure Act (APA) in 1946 as a comprehensive statute to regula...
In re Zurko isolated one of the oldest U.S. agencies from mainstream administrative law because the ...
Interactions between the PTO and the courts are more complex than for most agencies. PTO decisions m...
In Medicines Co. v. Hospira, Inc., 827 F.3d 1363 (Fed. Cir. 2016) (en banc), the United States filed...
Petitioner Oil States Energy Services sued respondent Greene’s Energy Group in a district court on s...
Among patent scholars who address institutional questions, many favor the courts over the PTO as the...
My objective in this Article is to demonstrate that the PTO\u27s patentability determinations are qu...
There is widespread agreement that the patent system in the United States is in need of reform. Most...
Whereas Congress has increasingly turned to administrative agencies to regulate complex technical ar...
The elaborate adjudicatory proceedings set up by the America Invents Act of 2011 (AIA) have thrust t...
Professors Field, Nard, and Duffy submitted an amicus brief to the Supreme Court in the case of Dick...
The high profile cases Bilski v. Kappos and Association for Molecular Pathology v. United States Pat...
My main objective is directed at institutional questions, to help the PTO and Congress as each consi...
Increasingly, accused infringers challenge a patent’s validity in two different forums: in litigatio...
Last month, the Supreme Court heard oral arguments for a case called Arthrex, Inc. v. United States ...
Congress enacted the Administrative Procedure Act (APA) in 1946 as a comprehensive statute to regula...
In re Zurko isolated one of the oldest U.S. agencies from mainstream administrative law because the ...
Interactions between the PTO and the courts are more complex than for most agencies. PTO decisions m...
In Medicines Co. v. Hospira, Inc., 827 F.3d 1363 (Fed. Cir. 2016) (en banc), the United States filed...
Petitioner Oil States Energy Services sued respondent Greene’s Energy Group in a district court on s...
Among patent scholars who address institutional questions, many favor the courts over the PTO as the...
My objective in this Article is to demonstrate that the PTO\u27s patentability determinations are qu...
There is widespread agreement that the patent system in the United States is in need of reform. Most...
Whereas Congress has increasingly turned to administrative agencies to regulate complex technical ar...
The elaborate adjudicatory proceedings set up by the America Invents Act of 2011 (AIA) have thrust t...
Professors Field, Nard, and Duffy submitted an amicus brief to the Supreme Court in the case of Dick...
The high profile cases Bilski v. Kappos and Association for Molecular Pathology v. United States Pat...
My main objective is directed at institutional questions, to help the PTO and Congress as each consi...
Increasingly, accused infringers challenge a patent’s validity in two different forums: in litigatio...
Last month, the Supreme Court heard oral arguments for a case called Arthrex, Inc. v. United States ...